Comparing Leukine vs Neulasta
| Leukine (sargramostim) | Neulasta (pegfilgrastim) |
|
|---|
| Leukine (sargramostim) | Neulasta (pegfilgrastim) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Aplastic Anemia, Bone Marrow Transplantation, Bone Marrow Transplantation - Failure or Engraftment Delay, Bone Marrow Transplantation - Myeloid Reconstruction, Hematopoietic Syndrome... View more |
Prescription only
Neulasta injection is a prescription medicine that may be given once every chemotherapy cycle to prevent febrile neutropenia in those people at high risk of it because of cancer treatments they are... View more |
Related suggestions Neutropenia Associated with Chemotherapy
Hematopoietic Syndrome of Acute Radiation Syndrome
Neutropenia Associated with Radiation
Popular comparisons
|
|||||||||||||||
| More about Leukine (sargramostim) | More about Neulasta (pegfilgrastim) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Neulasta has an average rating of 5.1 out of 10 from a total of 71 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 45% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Leukine side effects |
View all Neulasta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Leukine prices |
View all Neulasta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
3.84 hours |
80 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 186 drugs are known to interact with Leukine:
|
A total of 178 drugs are known to interact with Neulasta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 05, 1991 |
January 31, 2002 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Promacta
Promacta is used to prevent bleeding episodes in patients with chronic immune (idiopathic) ...
Alvaiz
Alvaiz (eltrombopag) is an oral thrombopoietin receptor agonist that may be used to treat certain ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Eltrombopag
Eltrombopag is used for aplastic anemia, immune thrombocytopenia, thrombocytopenia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.